Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G and IL-10 expression in human cancer—different stories with the same message
Mirjana Urosevic, Reinhard Dummer
Seminars in Cancer Biology (2003) Vol. 13, Iss. 5, pp. 337-342
Closed Access | Times Cited: 104

Showing 26-50 of 104 citing articles:

Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients
Philipp Schütt, Birgit Schütt, Magdalena Switala, et al.
Human Immunology (2010) Vol. 71, Iss. 5, pp. 489-495
Closed Access | Times Cited: 66
Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer
Aifen Lin, Chengsong Zhu, H.‐X. Chen, et al.
Journal of Cellular and Molecular Medicine (2009) Vol. 14, Iss. 9, pp. 2318-2329
Open Access | Times Cited: 59
Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer
Josefa Antonia Rodrı́guez, Liliana Galeano, Diana Palacios, et al.
Pathobiology (2011) Vol. 79, Iss. 2, pp. 72-83
Open Access | Times Cited: 57
Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer
Ebrahim Eskandari‐Nasab, Mohammad Hashemi, Seyed‐Shahaboddin Hasani, et al.
Cancer Biomarkers (2013) Vol. 13, Iss. 4, pp. 253-259
Closed Access | Times Cited: 51
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors
Jacek R. Wilczyński, Marek Nowak
Experientia supplementum (2022), pp. 1-57
Closed Access | Times Cited: 19
Expression of IL-10 in patients with ovarian carcinoma.
Alexander Mustea, Dominique Könsgen, Elena Ioana Braicu, et al.
PubMed (2006) Vol. 26, Iss. 2C, pp. 1715-8
Closed Access | Times Cited: 62
Serum IL-8 and IL-12 levels in breast cancer
Duygu Derin, Hilal Oğuz, Neşe Güney, et al.
Medical Oncology (2007) Vol. 24, Iss. 2, pp. 163-168
Closed Access | Times Cited: 59
Expression and regulation of non‐classical HLA‐G in renal cell carcinoma
K. Dunker, Gerald Schlaf, Juergen Bukur, et al.
Tissue Antigens (2008) Vol. 72, Iss. 2, pp. 137-148
Closed Access | Times Cited: 58
Thymosin beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation
Yuqing Zhang, Louis W. Feurino, Qihui Zhai, et al.
Cancer Biology & Therapy (2008) Vol. 7, Iss. 3, pp. 419-423
Open Access | Times Cited: 52
Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study.
Shailendra Dwivedi, Apul Goel, Shanker Madhav Natu, et al.
PubMed (2011) Vol. 12, Iss. 7, pp. 1843-8
Closed Access | Times Cited: 46
Positive feedback regulation between IL10 and EGFR promotes lung cancer formation
Tsung‐I Hsu, Yi-Chang Wang, Chia-Yang Hung, et al.
Oncotarget (2016) Vol. 7, Iss. 15, pp. 20840-20854
Open Access | Times Cited: 36
HLA-G gene activation in tumor cells involvescis-acting epigenetic changes
Ga�l Mouillot, C�line Marcou, Philippe Rousseau, et al.
International Journal of Cancer (2004) Vol. 113, Iss. 6, pp. 928-936
Open Access | Times Cited: 60
Clinical and biological significance of HLA-G expression in ovarian cancer
Jim Jinn‐Chyuan Sheu, Ie‐Ming Shih
Seminars in Cancer Biology (2007) Vol. 17, Iss. 6, pp. 436-443
Open Access | Times Cited: 50
Expression of human leukocyte antigen-G in systemic lupus erythematosus
Silvia Rosado, Gema Pérez-Chacón, Susana Mellor‐Pita, et al.
Human Immunology (2008) Vol. 69, Iss. 1, pp. 9-15
Closed Access | Times Cited: 49
Differential CD40/CD40L Expression Results in Counteracting Antitumor Immune Responses
Gopal Murugaiyan, Reena Agrawal-Rajput, Gyan C. Mishra, et al.
The Journal of Immunology (2007) Vol. 178, Iss. 4, pp. 2047-2055
Open Access | Times Cited: 45
Characterization of HLA‐G expression in renal cell carcinoma
B.‐L. Li, Aifen Lin, X.‐J. Zhang, et al.
Tissue Antigens (2009) Vol. 74, Iss. 3, pp. 213-221
Open Access | Times Cited: 45
Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma
Eulalia Catamo, Luisa Zupin, Sérgio Crovella, et al.
Human Immunology (2014) Vol. 75, Iss. 12, pp. 1225-1231
Closed Access | Times Cited: 33
Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
Mirjana Urosevic, Jivko Kamarashev, Günter Burg, et al.
Blood (2003) Vol. 103, Iss. 5, pp. 1796-1798
Open Access | Times Cited: 52
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor‐induced immunosuppression
Yongmei Yang, Alei Feng, Chengjun Zhou, et al.
Cancer Science (2011) Vol. 102, Iss. 7, pp. 1264-1271
Open Access | Times Cited: 29
Cancer: Tumor Iron Metabolism, Mitochondrial Dysfunction and Tumor Immunosuppression; “A Tight Partnership—Was Warburg Correct?”
Robert L. Elliott, Jonathan F. Head
Journal of Cancer Therapy (2012) Vol. 03, Iss. 04, pp. 278-311
Open Access | Times Cited: 28
IL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulating one?
Fernanda Costa Brandão Berti, Karen Brajão de Oliveira
AIMS Allergy and Immunology (2018) Vol. 2, Iss. 2, pp. 88-97
Open Access | Times Cited: 24
Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy
Joanna Rossowska, Natalia Anger, Agnieszka Szczygieł, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 24
Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment
S. Tubin, Mohammad K. Khan, Seema Gupta, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 775-775
Open Access | Times Cited: 19
Immunological modulation of the Th1/Th2 shift by ionizing radiation in tumors (Review)
Jiali Li, Zihang Zeng, Qiuji Wu, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 1
Open Access | Times Cited: 19
Functional Dichotomy in CD40 Reciprocally Regulates Effector T Cell Functions
Gopal Murugaiyan, Reena Agrawal-Rajput, Gyan C. Mishra, et al.
The Journal of Immunology (2006) Vol. 177, Iss. 10, pp. 6642-6649
Open Access | Times Cited: 39

Scroll to top